T lymphocyte subsets in primary antiphospholipid syndrome.
T. Papo(Assistance Publique – Hôpitaux de Paris), Brigitte Autran(Sorbonne Université), C. Françès(Navarre Institute of Health Research), Éric Legac(Centre hospitalier universitaire d'Orléans), Patrice Debré(Centre National de la Recherche Scientifique), Pierre Grenot(Inserm), J.C. Pietté(Sorbonne Université), P Godeau(Normandie Université)
PubMed
December 1, 1994
Cited by 14
Related Papers
Pure Red-Cell Aplasia and Antierythropoietin Antibodies in Patients Treated with Recombinant Erythropoietin
|New England Journal of Medicine|2002|1.2k
The immune paradox of sarcoidosis and regulatory T cells
|The Journal of Experimental Medicine|2006|444
Towards an HBV cure: state-of-the-art and unresolved questions—report of the ANRS workshop on HBV cure
|Gut|2015|273
European Dermatology Forum S1‐guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes
|Journal of the European Academy of Dermatology and Venereology|2017|262